Weekly Intelligence · 6 articles
Vet Industry Intel: Feb 22 – Feb 28, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Acquisitions & M&A
Covetrus and MWI Animal Health agree to merge in $3.5 billion deal - DVM360
Covetrus and MWI Animal Health have agreed to merge in a $3.5 billion deal, as reported by DVM360.
Covetrus · MWI Animal Health · DVM360
Regulatory & Policy
FDA approves first and only second-generation Janus kinase inhibitor - DVM360
The FDA has approved the first and only second-generation Janus kinase inhibitor for veterinary use, according to reports by DVM360.
FDA · DVM360
FDA issues Emergency Use Authorizations for NWS meds for dogs, cats - Veterinary Practice News
The FDA has issued Emergency Use Authorizations for New World Screwworm (NWS) medications for dogs and cats.
FDA · Veterinary Practice News
Products & Technology
Wrap up: Merck Animal Health’s atinvicitinib tablets receive FDA approval, and other news - DVM360
Merck Animal Health received FDA approval for its atinvicitinib tablets, as highlighted in veterinary industry news.
Merck Animal Health · FDA · DVM360
FDA Approves NUMELVI from Merck Animal Health for the Control of Pruritus in Dogs - Pet Age
The FDA approved NUMELVI from Merck Animal Health for the control of pruritus in dogs.
Merck Animal Health · FDA · Pet Age
Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics - PR Newswire
Gallant has partnered with MWI Animal Health to distribute its anticipated FDA-conditionally approved stem cell therapy directly to veterinary clinics.
Gallant · MWI Animal Health